Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients
Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients
复制标题
S100A4过表达与青年胃癌进展及预后密切相关
DOI:
10.3892/ol.2013.1220
复制
发表时间:
2013-02
期刊:
影响因子:
2.9
通讯作者:
TIANHUI WANG
中科院分区:
文献类型:
--
作者:
HUA LI;ZIQUAN LIU;CHUANXIANG XU;YUNYUN CHEN;JIANWEI ZHANG;BO CUI;XUEWEI CHEN;GAIHONG AN;XIAOJUN SHE;HONGTAO LIU;ZIFENG JIANG;TIANHUI WANG
.The aim of this study was to determine the correlation of S100A4 expression with the progression, prognosis and clinical pathology of gastric cancer (GC) in young pateints. A total of 85 tumor tissues with corresponding adjacent normal tissues and 62 non‑metastatic lymph nodes (LNs) with corresponding metastatic LNs were obtained from young GC patients (<40 years old) who underwent surgery between January 2001 and December 2006. The expression of S100A4 was detected by RT‑PCR and immunohistochemistry. Differences in the expression of S100A4 mRNA or protein were observed among the GC tissues, matched normal gastric mucosa, non‑metastatic LNs and metastatic LNs. The expression of S100A4 mRNA and protein in GC tissues and metastatic LNs was significantly higher compared with that in the matched normal gastric mucosa and non‑metastatic LNs, respectively (P<0.05). The overexpression of S100A4 was significantly associated with parameters involved in tumor progression and poor prognosis, including tumor size (P=0.017), Lauren classification (P=0.002), histological classification (P=0.010), histological differentiation (P=0.000), Borrmann classification (P=0.020), tumor‑node‑metastasis (TNM) stage (P=0.000), LN metastasis (P=0.000) and distant metastasis (P=0.024). Multivariate analysis suggested that patient age (P=0.035), tumor size (P=0.002), TNM stage (P=0.001) and S100A4 upregulation (P=0.000) were independent prognostic indicators for the disease. The overexpression of S100A4 in young GC patients is significantly associated with the clinicopathological characteristics. S100A4 maybe used as a biomarker to predict the progression and poor prognosis of GC in young...
登录
查看更多内容
影响因子:
--
作者:
Chin-Yau Chen;Chew-Wen Wu;S. Lo;M. Hsieh;W. Lui;K. Shen
通讯作者:
Chin-Yau Chen;Chew-Wen Wu;S. Lo;M. Hsieh;W. Lui;K. Shen
影响因子:
2.1
作者:
Matsumoto, Kazumasa;Irie, Akira;Baba, Shiro
通讯作者:
Baba, Shiro
影响因子:
4.8
作者:
Lee, Ok-Jae;Hong, Seung-Mo;El-Rifai, Wael
通讯作者:
El-Rifai, Wael
影响因子:
10.3
作者:
Sack, Ulrike;Walther, Wolfgang;Stein, Ulrike
通讯作者:
Stein, Ulrike
DOI:
--
发表时间:
2000-11
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Y. Yonemura;Y. Endou;K. Kimura;S. Fushida;E. Bandou;K. Taniguchi;K. Kinoshita;I. Ninomiya;K. Sugiyama;C. Heizmann;B. Schafer;Takuma Sasaki
通讯作者:
Y. Yonemura;Y. Endou;K. Kimura;S. Fushida;E. Bandou;K. Taniguchi;K. Kinoshita;I. Ninomiya;K. Sugiyama;C. Heizmann;B. Schafer;Takuma Sasaki